论文部分内容阅读
目的:观察三子止咳胶囊联合常规西医疗法治疗慢性支气管炎急性发作期患者的临床效果。方法:选取86例痰湿阻肺型慢性支气管炎急性发作期患者作为研究对象,通过随机数字表法分为观察组与对照组各43例,对照组行常规治疗,服用盐酸氨溴索片、阿莫西林胶囊、氨茶碱缓释片,观察组在对照组治疗基础上加用三子止咳胶囊,观察2组患者的治疗效果、症状体征缓解情况及不良反应发生情况。结果:治疗总有效率观察组为97.67%,对照组为81.40%,2组比较,差异有统计学意义(P<0.01)。观察组咯痰、咳嗽、喘息及肺部啰音的缓解时间均短于对照组,差异均有统计学意义(P<0.01)。观察组与对照组不良反应发生率分别为11.63%、9.30%,2组比较,差异无统计学意义(P>0.05),均未出现严重反应。结论:采用三子止咳胶囊联合常规西医疗法治疗慢性支气管炎急性发作期,可有效提高疗效,促进症状改善,且安全性高。
Objective: To observe the clinical effect of Sanzi Cough Capsule combined with routine western medicine in the treatment of patients with acute exacerbation of chronic bronchitis. Methods: Eighty-six patients with phlegm-damp lung chronic bronchitis were selected as the research object. The patients in the observation group and the control group were randomly divided into observation group (n = 43) and control group (n = 43). The control group received routine treatment and ambroxol hydrochloride tablets Amoxicillin capsules and aminophylline sustained-release tablets. The observation group was given Sanzi Cough Capsule on the basis of the control group. The therapeutic effect, symptom and symptom relief and adverse reactions of the two groups were observed. Results: The total effective rate was 97.67% in the observation group and 81.40% in the control group. There was significant difference between the two groups (P <0.01). The observation group, sputum, cough, wheezing and pulmonary remission time were shorter than the control group, the difference was statistically significant (P <0.01). The incidence of adverse reactions in the observation group and the control group were 11.63% and 9.30%, respectively. There was no significant difference between the two groups (P> 0.05). No serious reaction was observed. Conclusion: The Sanzi Cough Capsule combined with conventional Western medical treatment of acute exacerbation of chronic bronchitis can effectively improve the efficacy and promote the improvement of symptoms, and high safety.